153 related articles for article (PubMed ID: 34728779)
1. A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers.
Castro SR; Ribeiro LNM; Breitkreitz MC; Guilherme VA; Rodrigues da Silva GH; Mitsutake H; Alcântara ACS; Yokaichiya F; Franco MKKD; Clemens D; Kent B; Lancellotti M; de Araújo DR; de Paula E
Sci Rep; 2021 Nov; 11(1):21463. PubMed ID: 34728779
[TBL] [Abstract][Full Text] [Related]
2. Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo.
Liu X; Zhao Q
Biomed Pharmacother; 2019 Sep; 117():109057. PubMed ID: 31203133
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry.
Ribeiro LN; Franz-Montan M; Breitkreitz MC; Alcântara AC; Castro SR; Guilherme VA; Barbosa RM; de Paula E
Eur J Pharm Sci; 2016 Oct; 93():192-202. PubMed ID: 27543066
[TBL] [Abstract][Full Text] [Related]
4. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.
Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E
Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230
[TBL] [Abstract][Full Text] [Related]
5. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
6. Articaine in functional NLC show improved anesthesia and anti-inflammatory activity in zebrafish.
Rodrigues da Silva GH; Geronimo G; García-López JP; Ribeiro LNM; de Moura LD; Breitkreitz MC; Feijóo CG; de Paula E
Sci Rep; 2020 Nov; 10(1):19733. PubMed ID: 33184457
[TBL] [Abstract][Full Text] [Related]
7. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
9. Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC).
Teeranachaideekul V; Morakul B; Boonme P; Pornputtapitak W; Junyaprasert V
J Oleo Sci; 2020; 69(12):1627-1639. PubMed ID: 33268665
[TBL] [Abstract][Full Text] [Related]
10. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
11. Optimization of nanostructured lipid carriers for Zidovudine delivery using a microwave-assisted production method.
Cavalcanti SMT; Nunes C; Costa Lima SA; Soares-Sobrinho JL; Reis S
Eur J Pharm Sci; 2018 Sep; 122():22-30. PubMed ID: 29933076
[TBL] [Abstract][Full Text] [Related]
12. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
Ferreira M; Chaves LL; Lima SA; Reis S
Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.
Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Sousa Lobo JM; Amaral MH
Pharm Dev Technol; 2017 May; 22(3):336-349. PubMed ID: 28240141
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
15. Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
Yang Y; Qiu D; Liu Y; Chao L
Drug Des Devel Ther; 2019; 13():3307-3319. PubMed ID: 31571832
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
You P; Yuan R; Chen C
Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
[TBL] [Abstract][Full Text] [Related]
17. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
18. Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect.
Basha M; Abd El-Alim SH; Kassem AA; El Awdan S; Awad G
Curr Drug Deliv; 2015; 12(6):680-92. PubMed ID: 26138680
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR).
Mitsutake H; Ribeiro LNM; Rodrigues da Silva GH; Castro SR; de Paula E; Poppi RJ; Breitkreitz MC
Eur J Pharm Sci; 2019 Jul; 135():51-59. PubMed ID: 31071439
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.
Chinsriwongkul A; Chareanputtakhun P; Ngawhirunpat T; Rojanarata T; Sila-on W; Ruktanonchai U; Opanasopit P
AAPS PharmSciTech; 2012 Mar; 13(1):150-8. PubMed ID: 22167418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
